Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DTYMK | P23919 | 4/20 | 0.69 |
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | RNASEL | Q05823 | 7/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29306731 | 1.00 | DTYMK (0.69) | DTYMKF2RNASEL | |
| SCHEMBL25895079 | 0.96 | DTYMK (0.70) | DTYMKF2RNASEL | |
| SCHEMBL25896356 | 0.96 | DTYMK (0.70) | DTYMKF2RNASEL | |
| SCHEMBL27421857 | 0.94 | DTYMK (0.68) | DTYMKF2RNASEL | |
| SCHEMBL19147022 | 0.94 | DTYMK (0.62) | DTYMKF2RNASEL | |
| SCHEMBL27411508 | 0.94 | DTYMK (0.67) | DTYMKF2RNASEL | |
| SCHEMBL27410764 | 0.93 | DTYMK (0.67) | DTYMKF2RNASEL | |
| SCHEMBL21299317 | 0.92 | DTYMK (0.63) | DTYMKF2RNASEL | |
| SCHEMBL19147041 | 0.91 | DTYMK (0.59) | DTYMKF2RNASEL | |
| SCHEMBL25895053 | 0.88 | DTYMK (0.67) | DTYMKRNASEL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230233475-A1 | LIPID NANOPARTICLES CONTAINING POLYNUCLEOTIDES ENCODING GLUCOSE-6-PHOSPHATASE AND USES THEREOF | ARES CAPITAL CORPORATION, AS AGENT | 2023-07-27 | — | — | US | disclosed |
| US-20230130155-A1 | MRNAS ENCODING METABOLIC REPROGRAMMING POLYPEPTIDES AND USES THEREOF | ARES CAPITAL CORPORATION, AS AGENT | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230233475-A1 | LIPID NANOPARTICLES CONTAINING POLYNUCLEOTIDES ENCODING GLUCOSE-6-PHOSPHATASE AND USES THEREOF | G6PC1, GNPDA1, GPI | DTYMK 1763/4885F2 4882/4885RNASEL 775/4885 |
| US-20230130155-A1 | MRNAS ENCODING METABOLIC REPROGRAMMING POLYPEPTIDES AND USES THEREOF | HMOX1, CD209, HMOX2 | DTYMK 353/4885F2 4866/4885RNASEL 990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.